GENERIC SOVALDI is a groundbreaking Hepatitis C (Hep C) treatment. Clinical studies have shown that GENERIC SOVALDI combination therapy can be effective for people with genotypes 1, 2, 3, and 4.
Talk to your doctor and see how our team can help leading the way with a breakthrough treatment for Hepatitis C
Generic Sovaldi is a breakthrough medication that was developed to treat Hepatitis C virus (HCV) infection. The active ingredient of Generic Sovaldi is Sofosbuvir 400mg. As a nucleotide analog inhibitor, it restrains the NS5B protein from replicating the HCV in human body, thus providing an effective treatment for the infection.
Sofosbuvir was developed and patented by Gilead Sciences under the
brand name Sovaldi. The average price for the brand Sofosbuvir course varies between 80 and over 160 thousands dollars. In September 2014 Gilead Sciences allowed several other Pharmaceutical companies to produce Generic Sofosbuvir and sell it to 91 developing countries, thus giving the indigent patients a chance to recover from Hepatitis C.